Arbutus Biopharma Corporation (ABUS): Investor Stock Updates: Tekmira Pharmace...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	113
Posts	25553
Boards Moderated	4
Alias Born	02/01/2004

Ubertino

Re: None

Sunday, 12/07/2014 4:03:40 PM

Sunday, December 07, 2014 4:03:40 PM

Investor Stock Updates: Tekmira Pharmaceuticals Corp

by WENDY KNIGHT
December 5, 2014

As much as 6 analysts have advised buy on Tekmira Pharmaceuticals Corp (NASDAQ:TKMR) with an average broker rating of 1.83. Zacks research analysts are highly optimistic on the counter and has given it a short term rating of 1, indicating that it is a strong buy. Tekmira Pharmaceuticals Corp (NASDAQ:TKMR) faced a 4.13% cut in its share price in the most recent trading session. Bearish sentiments were clearly visible in the counter as the shares, which had opened at $13.6, failed to make any significant gains due to the relentless selling pressure, which saw the share price drop to $12.88. The last trade was registered at $13.01, down 0.56 points, and the volume was measured at 674,044 shares. The shares had closed the previous day trading session at $13.57. The company has a market cap of $290 million and the 52-week high of the share price is $31.48.

http://dailyjoplin.com/investor-stock-updates-tekmira-pharmaceuticals-corp-cubist-pharmaceuticals/39877/